Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunction
View Patent ↗The use of acetyl L-carnitine in combination with propionyl L-carnitine and sildenafil is described for the preparation of a medicament and/or dietetic product for the treatment of erectile dysfunction secondary to all those conditions in which there is distress or iatrogenic damage of the lesser pelvis within which the neurovascular bundles of the penis run.
1. Method of treating erectile dysfunction in a patient who has undergone retropubic prostatectomy consisting of
administering to a patient who has undergone retropubic prostatectomy a combination consisting of
2 g of acetyl L-carnitine, 2 g of propionyl L-carnitine or a pharmaceutically acceptable salt thereof; and
sildenafil, in their various pharmaceutical preparations.
2. The method of claim 1 , in which the pharmaceutically acceptable salt is selected from the group consisting of chloride, bromide, orotate, aspartate, acid aspartate, citrate, acid citrate, magnesium citrate, phosphate, acid phosphate, fumarate, acid fumarate, magnesium fumarate, glycerophosphate, lactate, maleate and acid maleate, mucate, oxalate, acid oxalate, pamoate, acid pamoate, sulphate , acid sulphate, glucose phosphate, tartrate, acid tartrate, magnesium tartrate, 2-amino ethanesulphonate, magnesium 2-amino ethanesulphonate, methanesulphonate, choline tartrate, trichloroacetate and trifluoroacetate.
3. A composition consisting of
a) 2 g of acetyl L-carnitine, 2 g of propionyl L-carnitine or pharmaceutically acceptable salts thereof;
b) sildenafil; and
c) at least one pharmaceutically acceptable excipient or diluent.
4. A composition consisting of
a) 2 g of acetyl L-carnitine, 2 g of propionyl L-carnitine or pharmaceutically acceptable salts thereof;
b) sildenafil; and
c) at least one pharmaceutically acceptable excipient or diluent, one or more vitamins and lipophilic or hydrophilic antioxidants.